ScholarLens Back to search
2018•Annals of OncologyOpen access

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo Giovanni Casali, Nuno Abecassis, Sebastian Bauer, Roberto Biagini, Stefan S. Bielack, Sylvie Bonvalot, Ioannis P. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, Alexander N. Fedenko, Virginia Ferraresi, Andrea C. Ferrari, Stefano A. Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans A. J. Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf Dieter Issels, Heikki Joensuu, Robin L. Jones, Ian Robert Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona A. Lugowska, Ofer Merimsky, Michael Montemurro, Maria Abbondanza Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin H. Robinson, Piotr Lukasz Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay

Open full text 1,635 citations

Abstract

Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular subsets, characterised by a low to very low incidence in all populations. The majority of sarcomas arise from the soft tissue (close to 75%), with ∼15% gastrointestinal stromal tumours (GISTs) and 10% bone sarcomas. These ESMO–EURACAN (European Society for Medical Oncology–European Reference Network for rare adult solid cancers) Clinical Practice Guidelines cover STSs, while GISTs are covered by dedicated ESMO–EURACAN Clinical Practice Guidelines [1].

Open-access reader

About this research paper

What this paper is about

Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular subsets, characterised by a low to very low incidence in all populations. The majority of sarcomas arise from the soft tissue (close to 75%), with ∼15% gastrointestinal stromal tumours (GISTs) and 10% bone sarcomas. These ESMO–EURACAN (European Society for Medical Oncology–European Reference Network for rare adult solid cancers) Clinical Practice Guidelines cover STSs, while GISTs are covered by dedicated ESMO–EURACAN Clinical Practice Guidelines [1].

Why it matters

OpenAlex reports 1635 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular subsets, characterised by a low to very low incidence in all populations. The majority of sarcomas arise from the soft tissue (close to 75%), with ∼15% gastrointestinal stromal tumours (GISTs) and 10% bone sarcomas. These ESMO–EURACAN (European Society for Medical Oncology–European Reference Network for rare adult solid cancers) Clinical Practice Guidelines cover STSs, while GISTs are covered by dedicated ESMO–EURACAN Clinical Practice Guidelines [1].

Key concepts: Medicine, Sarcoma, Soft tissue, Bone Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Clinical Practice, Myxofibrosarcoma

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up — Research Paper | ScholarLens